Edwards Lifesciences Total Assets 2010-2022 | EW

Edwards Lifesciences total assets from 2010 to 2022. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Edwards Lifesciences total assets for the quarter ending September 30, 2022 were $8.638B, a 5.86% increase year-over-year.
  • Edwards Lifesciences total assets for 2021 were $8.503B, a 17.49% increase from 2020.
  • Edwards Lifesciences total assets for 2020 were $7.237B, a 11.54% increase from 2019.
  • Edwards Lifesciences total assets for 2019 were $6.488B, a 21.87% increase from 2018.
Edwards Lifesciences Annual Total Assets
(Millions of US $)
2021 $8,503
2020 $7,237
2019 $6,488
2018 $5,324
2017 $5,666
2016 $4,510
2015 $4,056
2014 $3,523
2013 $2,710
2012 $2,222
2011 $1,981
2010 $1,767
2009 $1,616
Edwards Lifesciences Quarterly Total Assets
(Millions of US $)
2022-09-30 $8,638
2022-06-30 $8,425
2022-03-31 $8,420
2021-12-31 $8,503
2021-09-30 $8,160
2021-06-30 $7,662
2021-03-31 $7,214
2020-12-31 $7,237
2020-09-30 $6,801
2020-06-30 $6,424
2020-03-31 $6,076
2019-12-31 $6,488
2019-09-30 $5,966
2019-06-30 $5,574
2019-03-31 $5,469
2018-12-31 $5,324
2018-09-30 $5,958
2018-06-30 $5,686
2018-03-31 $5,825
2017-12-31 $5,666
2017-09-30 $5,488
2017-06-30 $5,139
2017-03-31 $4,780
2016-12-31 $4,510
2016-09-30 $4,339
2016-06-30 $4,051
2016-03-31 $3,854
2015-12-31 $4,056
2015-09-30 $3,877
2015-06-30 $3,608
2015-03-31 $3,488
2014-12-31 $3,523
2014-09-30 $3,350
2014-06-30 $3,327
2014-03-31 $2,652
2013-12-31 $2,710
2013-09-30 $2,531
2013-06-30 $2,340
2013-03-31 $2,297
2012-12-31 $2,222
2012-09-30 $2,196
2012-06-30 $2,075
2012-03-31 $2,004
2011-12-31 $1,981
2011-09-30 $1,983
2011-06-30 $2,002
2011-03-31 $1,931
2010-12-31 $1,767
2010-09-30 $1,725
2010-06-30 $1,642
2010-03-31 $1,604
2009-12-31 $1,616
2009-09-30 $1,602
2009-06-30 $1,465
2009-03-31 $1,359
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $46.932B $5.233B
Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $214.645B 22.45
Alcon (ALC) Switzerland $33.321B 28.69
STERIS (STE) Ireland $18.019B 22.42
Teleflex (TFX) United States $10.587B 17.18
Fresenius Medical Care AG KGaA (FMS) Germany $8.996B 9.03
Penumbra (PEN) United States $7.452B 1783.82
Globus Medical (GMED) United States $7.103B 36.11
Integer Holdings (ITGR) United States $2.367B 19.00
Glaukos (GKOS) United States $2.263B 0.00
Nevro (NVRO) United States $1.556B 0.00
Paragon 28 (FNA) United States $1.534B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.246B 17.74
Artivion (AORT) United States $0.520B 0.00